TY  - GEN
AU  - Lebwohl,M
TI  - Clinical efficacy and safety of tazarotene: optimizing clinical results
SN  - 0011-4162
PY  - 1999///0107
KW  - Administration, Topical
KW  - Adrenal Cortex Hormones
KW  - administration & dosage
KW  - Clinical Trials as Topic
KW  - Dermatologic Agents
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - Humans
KW  - Nicotinic Acids
KW  - Pilot Projects
KW  - Prognosis
KW  - Psoriasis
KW  - drug therapy
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Review
ER  -